Abstract
In addition to providing a timely and accurate diagnosis, pathologists routinely provide prognostic and predictive information to assist in the treatment of patients with invasive breast cancer. As our understanding of breast cancer at the molecular and genetic level improves, sophisticated new treatment options have become available to patients. The demonstrated improvements in disease-free and overall survival with the use of trastuzumab (Herceptin) has made HER2 testing a standard of care in the evaluation of patients with breast cancer. Specialized breast centers have accumulated sufficient experience to recognize that HER2 positive tumors tend to be of higher grade and to be estrogen receptor negative, whereas well-differentiated breast cancers rarely are HER2 positive. To determine whether HER2 testing is necessary in well-differentiated breast cancer, we analyzed the frequency of HER2 positivity among 1,162 cases from 7 major breast centers or commercial laboratories in the United States and Europe. Well-differentiated breast cancers, defined by either nuclear grading or the Scarff-Bloom-Richardson system, rarely are HER2 positive (mean 1.6%, range 0-2.8%). Given the low rate of well differentiated HER2 positive tumors, ...Continue Reading
References
Nov 1, 1989·Cancer·V Le DoussalM Brunet
Nov 6, 2001·Oncology·J Baselga
Jun 6, 2002·Journal of the National Cancer Institute·Patrick C RocheEdith A Perez
Oct 10, 2003·Cancer·Doo Ho ChoiBruce G Haffty
Dec 12, 2003·Cancer·Susanne TaucherRaimund Jakesz
Apr 29, 2004·JAMA : the Journal of the American Medical Association·Hadi YazijiAllen M Gown
May 28, 2004·Archives of Pathology & Laboratory Medicine·José María Vera-Román, Luis Alberto Rubio-Martínez
Jul 27, 2004·American Journal of Clinical Pathology·Anthony RhodesAngelo Paradiso
Nov 24, 2004·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Azadeh StarkJennifer Griggs
Jan 12, 2005·Cancer·Dipen MaruAysegul Sahin
May 27, 2005·Journal of Clinical Pathology·H J HuangM R Christiaens
Sep 3, 2005·Clinical Breast Cancer·Robert D MassDennis J Slamon
Sep 27, 2005·Breast Cancer Research and Treatment·Noël DybdalMichael F Press
Oct 7, 2005·Cancer·Azadeh T StarkJennifer Griggs
Jun 14, 2006·Virchows Archiv : an International Journal of Pathology·Anna SapinoGianni Bussolati
Aug 25, 2006·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hitoshi Tsuda
Aug 26, 2006·Breast Cancer Research and Treatment·Lisa M McShaneUNKNOWN Statistics Subcommittee of NCI-EORTC Working Group on Cancer Diagnostics
Jan 24, 2007·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jun 27, 2007·Cancer·Louis P GarrisonEdith A Perez
Jul 12, 2007·Journal of the National Cancer Institute·Rabiya S Tuma
Aug 10, 2007·BMC Cancer·Gustavo A VianiFrancisco V Soares
Aug 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melinda L TelliAlice E Guardino
Sep 13, 2007·Journal of the National Cancer Institute·Jessica D AlbanoMichael J Thun
May 20, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Allen M GownChristopher C Tse
Jan 1, 2007·Archives of Pathology & Laboratory Medicine·Antonio C WolffUNKNOWN American Society of Clinical Oncology/College of American Pathologists
Citations
Apr 23, 2011·Breast Cancer Research and Treatment·Anja BrügmannMogens Vyberg
Jun 18, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Joan AlbanellJosé Palacios
Feb 12, 2009·BMC Cancer·Seon-Ah HaJin Woo Kim
Oct 27, 2012·The Breast : Official Journal of the European Society of Mastology·Nirmala PathmanathanRosemary L Balleine
Jun 21, 2011·American Journal of Clinical Pathology·Jing YuRohit Bhargava
Dec 30, 2016·Histopathology·Gillian C BethunePenelope J Barnes
Dec 2, 2019·American Journal of Clinical Pathology·Huina ZhangDavid G Hicks
Apr 16, 2021·Pathology, Research and Practice·Carissa LaBoyJennifer L Pincus
Jul 3, 2021·International Journal of Molecular Sciences·Chris ViSarah Shigdar
Aug 8, 2021·Human Pathology·Xiao HuangAysegul A Sahin